Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Lenalidomide

EU orphan designation number: EU/3/15/1473   
Active ingredient: Lenalidomide
Indication: Treatment of marginal zone lymphoma
Sponsor: Celgene Europe Limited
1 Longwalk Road, Stockley Park, Uxbridge, Middlesex UB11 1DB, United Kingdom

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page
Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
28/04/2015 Orphan designation EMA/OD/284/14 (2015)2937 of 24/04/2015